RORA and melanoma: The upregulation of TIMELESS has also been found in cervical carcinoma [25], colorectal cancer [26], and breast cancer [27], and the downregulation of RORA has been found in many cancers including hepatocellular carcinoma [28], gastric cancer [29], melanoma [30], and breast cancer [31].